Varying 10-year off-treatment responses to nucleos(t)ide analogues in patients with chronic hepatitis B according to their pretreatment hepatitis B e antigen status-Reference-Cited by-同舟云学术

Varying 10-year off-treatment responses to nucleos(t)ide analogues in patients with chronic hepatitis B according to their pretreatment hepatitis B e antigen status

Published:2018-09 Issue:9 Volume:19 Page:561-571
ISSN:1751-2972
Container-title:Journal of Digestive Diseases
language:en
Short-container-title:Journal of Digestive Diseases

Author:

Liu Feng¹,Liu Zhi Rong¹²,Li Tao¹^ORCID,Liu You De³,Zhang Meng²,Xue Yan¹,Zhang Li Xin¹,Ye Qian¹,Fan Xiao Ping⁴,Wang Lei¹^ORCID

Affiliation:

1. Department of Infectious Diseases and Hepatology; Second Hospital of Shandong University; Jinan China

2. Jinan Infectious Disease Hospital, Shandong University School of Medicine; Jinan China

3. Department of Hepatology, Yantai Infectious Disease Hospital; Yantai China

4. Department of Hepatology, Qingdao Infectious Disease Hospital; Qingdao Shandong Province China

Funder

National Science and Technology Major Project

Project of Science and Technology Development Plan of Shandong Province

National Natural Science Foundation of China

Natural Science Foundation of Shandong Province

Publisher

Wiley

Subject

Gastroenterology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1751-2980.12654/fullpdf

Reference34 articles.

1. Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians;Arends;Gut,2015

2. Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate;Marcellin;J Hepatol,2014

3. Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy;Lai;Hepatology,2013

4. AASLD guidelines for treatment of chronic hepatitis B;Terrault;Hepatology,2016

5. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update;Sarin;Hepatol Int,2016

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive Value of HBsAg for Off-treatment Response in HBeAg-negative Chronic Hepatitis B Patients;Journal of the College of Physicians and Surgeons Pakistan;2023-01-01

2. Hepatocellular carcinoma after treatment cessation in non‐cirrhotic HBeAg‐negative chronic hepatitis B: A multicentre cohort study;Liver International;2021-12-20

3. Clinical management of chronic hepatitis B: A concise overview;United European Gastroenterology Journal;2021-11-30

4. Discontinuation of nucleot(s)ide analogue therapy in HBeAg-negative chronic hepatitis B: a meta-analysis;Gut;2021-09-07

5. APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients;Hepatology International;2021-07-23